The most common side effects are GI-related nausea, mild constipation, or occasional fatigue particularly when starting or increasing the dose
As it was previously mentioned semaglutide has a structure similar to GLP-1, however, three modifications were made to the peptide in order to ensure the safety of once-weekly semaglutide administration for clinical use
Your health and results depend on navigating this space correctly, which means avoiding the online marketplace and working exclusively with a medical professional who can provide access to high-quality, regulated compounds and create a safe, effective plan for you
Your doctor will adjust the dose according to your response to the treatment
To reduce hematocrit, therapeutic phlebotomy (blood donation or removal) is often recommended
There are currently 5-10 million people on a branded GLP-1 medication, but there is an estimated 50-60 million who are clinically eligible to receive Wegovy and have insurance coverage for it, and of those, millions could purchase it for a copay of less than $100/month
